| Followers | 843 |
| Posts | 123050 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Thursday, May 04, 2006 6:55:50 AM
> ADH IMHO, certainly qualifies as a Biotech Value! C'mon GSK step up to the plate!!!<
Patience—GSK is watching and waiting.
What do you make of the fact that the dosing level is 2,400mg/m2 in the European trial and 600mg/m2 in the North American trial. I understand that the MTD has not been reached in any trial to date but, even so, the dosing disparity between the two trials seems odd.
>Going fishing today and tomorrow!
<
During the week? You must be a dilettante
Patience—GSK is watching and waiting.
What do you make of the fact that the dosing level is 2,400mg/m2 in the European trial and 600mg/m2 in the North American trial. I understand that the MTD has not been reached in any trial to date but, even so, the dosing disparity between the two trials seems odd.
>Going fishing today and tomorrow!
< During the week? You must be a dilettante
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
